West Appoints Michel Lagarde to be President and Chief Executive Officer
West Pharmaceutical Services appointed Michel Lagarde as its new President and CEO, effective August 31, 2026, succeeding retiring CEO Eric M. Green. Lagarde brings extensive experience from Thermo Fisher Scientific, where he served as Executive VP and COO, and previously led operations at Patheon and Philips. The board also elected Robert F.
Key figures
- Global sites
- 50
- Team members
- 10000
- Fiscal 2025 net sales
- $3.07 billion
- Manufacturing facilities
- 26
- Annual components delivered
- 41 billion
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.